Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats

被引:15
|
作者
Takahashi, H [1 ]
Yoshimoto, M [1 ]
Higuchi, H [1 ]
Shimizu, T [1 ]
Hishikawa, Y [1 ]
机构
[1] Akita Univ, Sch Med, Dept Neuropsychiat, Akita 0108543, Japan
关键词
calcium-channel blocker; sleep; benzodiazepine hypnotic; non-benzodiazepine hypnotic; rat;
D O I
10.1016/S0924-977X(98)00051-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the effects of an L-type Ca2+ channel blocker, nilvadipine (0.5 and 2.0 mg/kg), and that of a T-type Ca2+ channel blacker, flunarizine (10.0 and 40.0 mg/kg), on the hypnotic potency of both a benzodiazepine (BZ)-hypnotic, triazolam (1.0 mg/kg), and a non-BZ hypnotic, zolpidem (20.0 mg/kg), in rats. The polysomnogram was recorded for 6 h after administration of the vehicle solution alone, or after one of the Ca2+ channel blockers, with or without one of the hypnotics. Both Ca2+ channel blockers prolonged the increased total time of non-rapid eye movement (non-REM) sleep induced by either hypnotic. In the case of triazolam, however, the non-REM sleep-enhancing effect induced by nilvadipine was greater than that induced by flunarizine. These findings indicate that the hypnotic action of triazolam is potentiated more strongly by an L-type Ca2+ channel blocker than by a T-type Ca2+ channel blocker. (C) 1999 Elsevier Science B.V./ECNP. All rights reserved.
引用
收藏
页码:317 / 321
页数:5
相关论文
共 50 条
  • [21] T-Type and N-Type Calcium Channel Blockers Attenuate Cardiac Sympathetic Nervous Activity More Effectively Compared With L-Type Calcium Channel Blocker in Patients with Hypertension
    Ogura, Chika
    Miyamoto, Shoichi
    Ikai, Akiko
    Tanaka, Shiro
    Fujita, Masatoshi
    CIRCULATION, 2011, 124 (21)
  • [22] THE ROLE OF T-TYPE CALCIUM CHANNEL BLOCKERS IN ANGIOGENESIS IN DIABETES
    Chan, Jenq-Shyong
    Wu, Tao-Cheng
    Chen, Jaw-Wen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [23] First pharmacophoric hypothesis for T-type calcium channel blockers
    Doddareddy, MR
    Jung, HK
    Lee, JY
    Lee, YS
    Cho, YS
    Koh, HY
    Pae, AN
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (07) : 1605 - 1611
  • [24] Towards the discovery of novel T-type calcium channel blockers
    Lory, Philippe
    Chemin, Jean
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (05) : 717 - 722
  • [25] Lead discovery and optimization of T-type calcium channel blockers
    Park, Jung Hwan
    Choi, Jin Kyu
    Lee, Eunjung
    Lee, Jae Kyun
    Rhim, Hyewhon
    Seo, Seon Hee
    Kim, Yoonjee
    Doddareddy, Munikumar Reddy
    Pae, Ae Nim
    Kang, Jahyo
    Roh, Eun Joo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (03) : 1409 - 1419
  • [26] Multifunctional L/N- and L/T-type calcium channel blockers for kidney protection
    Abe, Masanori
    Soma, Masayoshi
    HYPERTENSION RESEARCH, 2015, 38 (12) : 804 - 806
  • [27] Neuroprotective effects of blockers for T-type calcium channels
    Wildburger, Norelle C.
    Lin-Ye, Avary
    Baird, Michelle A.
    Lei, Debin
    Bao, Jianxin
    MOLECULAR NEURODEGENERATION, 2009, 4
  • [28] Neuroprotective effects of blockers for T-type calcium channels
    Norelle C Wildburger
    Avary Lin-Ye
    Michelle A Baird
    Debin Lei
    Jianxin Bao
    Molecular Neurodegeneration, 4
  • [29] Multifunctional L/N- and L/T-type calcium channel blockers for kidney protection
    Masanori Abe
    Masayoshi Soma
    Hypertension Research, 2015, 38 : 804 - 806
  • [30] Combined L-/T-Type Calcium Channel Blockers Ready for Prime Time
    Ge, Wei
    Ren, Jun
    HYPERTENSION, 2009, 53 (04) : 592 - 594